688399 硕世生物
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额96,621(113,144)1,964,878985,523935,881
投资活动产生之现金流量净额(631,706)462,348(717,888)(748,635)(259,598)
筹资活动产生之现金流量净额(3,569)55,259(667,426)(234,003)(125,894)
汇率变动对现金及现金等价物的影响(1,439)(1,266)757(1,535)(1,632)
现金及现金等价物净增加/(减少)(540,094)403,197580,3221,350548,757
期初现金及现金等价物余额1,631,0021,227,805647,483646,13397,375
期末现金及现金等价物余额1,090,9081,631,0021,227,805647,483646,133